title: Toxicities and Adverse Drug Reactions Experienced During Anticancer Treatment: It Is Desirable to Consider the Problem Within the International System of Pharmacovigilance.
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy pbaldo@cro.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Baldo
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Fornasier
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Francescon
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy.
authors.forename: Emanuela
authors.initials: E
authors.lastname: Ferrarin
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy.
authors.forename: Ivana
authors.initials: I
authors.lastname: Truccolo
authors.affiliation: CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy.
authors.forename: Paolo
authors.initials: P
authors.lastname: De Paoli
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male
chemical_list: D000970:Antineoplastic Agents